News
The 52-week study (ClinicalTrials.gov Identifier: NCT05013229) included 679 adults with type 2 diabetes who were inadequately controlled with basal insulin.
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.
Aug. 27, 2024 – People with type 2 diabetes can now wear a device that will automatically deliver doses of insulin, following an expanded approval by the FDA on Monday.
In QWINT-3, 986 adults with type 2 diabetes who were using basal insulin and up to three glucose-lowering drugs at baseline without prandial insulin were enrolled (median age, 62 years; 44% women).
Hosted on MSN1y
Medications for Type 2 Diabetes - MSNMedically reviewed by Lindsay Cook, PharmD Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), insulin resistance, and a decrease in insulin production. For some ...
Eli Lilly’s once-weekly insulin injection is just as effective as daily insulin shots for managing A1C levels in diabetes, according to the latest results from two phase 3 clinical trials.
Hosted on MSN1mon
Once-weekly insulin promising for type 2 diabetes - MSNEli Lilly’s LLY.N experimental once-weekly insulin efsitora was comparable to daily insulins in nearly a thousand adults with type 2 diabetes in three late-stage trials, researchers reported at ...
3d
News-Medical.Net on MSNImmune aging drives the progression of type 2 diabetesType 2 diabetes (T2D) is a global metabolic epidemic driven by insulin resistance (IR), chronic inflammation, and β-cell ...
Most people know of Type 1 and Type 2 diabetes, but not all know how their causes differ. We asked Dr. Rodica Busui, the president of Medicine and Science at the American Diabetes Association.
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available ...
Tirzepatide, Mounjaro, is already a primary type 2 diabetes medication, but could also work as an adjunct treatment, according to new research. The drug, when used alongside basal insulin, appears ...
“What looks like insulin resistance can be misdiagnosed as type 2 diabetes when you actually have type 1,” says Aimée José, RN, CDCES, a diabetes educator in private practice in the San ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results